NO20000063L - Nye IL-5 inhiberende 6-azauracilderivater - Google Patents
Nye IL-5 inhiberende 6-azauracilderivaterInfo
- Publication number
- NO20000063L NO20000063L NO20000063A NO20000063A NO20000063L NO 20000063 L NO20000063 L NO 20000063L NO 20000063 A NO20000063 A NO 20000063A NO 20000063 A NO20000063 A NO 20000063A NO 20000063 L NO20000063 L NO 20000063L
- Authority
- NO
- Norway
- Prior art keywords
- optionally substituted
- alkyl
- cycloalkyl
- aryl
- hydrogen
- Prior art date
Links
- SSPYSWLZOPCOLO-UHFFFAOYSA-N 6-azauracil Chemical class O=C1C=NNC(=O)N1 SSPYSWLZOPCOLO-UHFFFAOYSA-N 0.000 title 1
- 108010002616 Interleukin-5 Proteins 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 125000003118 aryl group Chemical group 0.000 abstract 6
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 4
- 150000002431 hydrogen Chemical class 0.000 abstract 4
- 125000001424 substituent group Chemical group 0.000 abstract 4
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 abstract 4
- -1 Het 1 Chemical group 0.000 abstract 3
- 125000001475 halogen functional group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000005129 aryl carbonyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004953 trihalomethyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97202118 | 1997-07-10 | ||
| PCT/EP1998/004191 WO1999002505A1 (en) | 1997-07-10 | 1998-07-07 | Il-5 inhibiting 6-azauracil derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20000063D0 NO20000063D0 (no) | 2000-01-06 |
| NO20000063L true NO20000063L (no) | 2000-03-10 |
Family
ID=8228531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000063A NO20000063L (no) | 1997-07-10 | 2000-01-06 | Nye IL-5 inhiberende 6-azauracilderivater |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1000040B1 (de) |
| JP (1) | JP2002511882A (de) |
| KR (1) | KR20010014049A (de) |
| CN (1) | CN1262679A (de) |
| AR (1) | AR013360A1 (de) |
| AT (1) | ATE364597T1 (de) |
| AU (1) | AU742145B2 (de) |
| BR (1) | BR9811678A (de) |
| CA (1) | CA2294145A1 (de) |
| DE (1) | DE69837922D1 (de) |
| EE (1) | EE200000016A (de) |
| HR (1) | HRP20000003A2 (de) |
| HU (1) | HUP0004687A3 (de) |
| ID (1) | ID24390A (de) |
| IL (1) | IL133916A0 (de) |
| NO (1) | NO20000063L (de) |
| NZ (1) | NZ502180A (de) |
| PL (1) | PL337947A1 (de) |
| SK (1) | SK183999A3 (de) |
| TR (1) | TR200000153T2 (de) |
| TW (1) | TW496865B (de) |
| WO (1) | WO1999002505A1 (de) |
| ZA (1) | ZA986089B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2230880T3 (es) * | 1998-07-30 | 2005-05-01 | Abbott Laboratories | Agentes selectivos anti-inflmatorios de glucocorticoides. |
| EP0987265A1 (de) | 1998-09-18 | 2000-03-22 | Janssen Pharmaceutica N.V. | Interleukin-5 hemmende 6-Azauracil Derivate |
| PL198205B1 (pl) * | 1998-12-18 | 2008-06-30 | Janssen Pharmaceutica Nv | Inhibitująca IL-5 pochodna 6-azauracylu, jej zastosowanie i sposób wytwarzania, kompozycja farmaceutyczna, sposób znaczenia in vitro receptora i sposób obrazowania in vitro narządu |
| EA004740B1 (ru) * | 1999-08-06 | 2004-08-26 | Янссен Фармацевтика Н.В. | Интерлейкин-5 ингибирующие производные 6-азаурацила |
| US6743820B2 (en) | 2000-07-07 | 2004-06-01 | University Of Toledo | Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor |
| US7183276B2 (en) | 2002-02-28 | 2007-02-27 | Takeda Pharmaceutical Company Limited | Azole compounds |
| WO2004071448A2 (en) * | 2003-02-12 | 2004-08-26 | Transtech Pharma Inc. | Substituted azole derivatives as inhibitors of protein tyrosine phosphatases |
| GB0305575D0 (en) | 2003-03-11 | 2003-04-16 | Glaxo Group Ltd | Novel compounds |
| EP1758874A1 (de) * | 2004-05-29 | 2007-03-07 | 7TM Pharma A/S | Substituierte thiazolessigsäuren als crth2-liganden |
| DE102006049618A1 (de) * | 2006-10-20 | 2008-05-08 | Tschesche, Harald, Prof. Dr. | Triazine und Ihre Verwendung als Metalloproteinase-Inhibitoren |
| CN101265238B (zh) * | 2007-12-12 | 2010-06-16 | 重庆天极旅业有限公司 | 一种三嗪环衍生物的合成方法 |
| CN101265216B (zh) * | 2007-12-18 | 2012-06-27 | 重庆华邦胜凯制药有限公司 | 4-(取代乙氰基)-苯腙衍生物及其合成方法 |
| AU2011292285A1 (en) * | 2010-08-16 | 2013-01-31 | Boehringer Ingelheim International Gmbh | Oxadiazole inhibitors of leukotriene production |
| SG11201900215YA (en) * | 2016-07-13 | 2019-02-27 | Univ Paris Descartes | Meclozine derivatives and diclazuril derivatives for use in the prevention and/or the treatment of disorders associated to the inflammation induced by p. acnes |
| JP2022547882A (ja) * | 2019-09-06 | 2022-11-16 | インフレイゾーム リミテッド | Ｎｌｒｐ３阻害剤 |
| CN120346211B (zh) * | 2025-06-20 | 2025-10-24 | 中国科学技术大学 | 二苯乙腈类化合物的用途及蛋白质靶向水解嵌合体类化合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2149645A1 (de) * | 1970-10-07 | 1972-09-14 | Pfizer | 2-Phenyl-as-triazin-3.5-(2H,4H)-dione und die Verwendung dieser Verbindungen zur Bekaempfung der Coccidiose |
| US3912723A (en) * | 1971-03-29 | 1975-10-14 | Pfizer | 2-Phenyl-as-triazine-3,5(2H,4H)diones |
| US3883528A (en) * | 1974-04-19 | 1975-05-13 | Pfizer | Preparation of 2(aryl)-as-triazine-3,5(2H,4H)-dione coccidiostats |
| CA1244024A (en) * | 1984-08-01 | 1988-11-01 | Gustaaf M. Boeckx | .alpha.- ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN- 2(3H)-YL)BENZENEACETONITRILES |
| GB8602342D0 (en) * | 1986-01-30 | 1986-03-05 | Janssen Pharmaceutica Nv | 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones |
| EP0476439A1 (de) * | 1990-09-18 | 1992-03-25 | Bayer Ag | Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung |
| TW403741B (en) * | 1993-10-15 | 2000-09-01 | Takeda Chemical Industries Ltd | Triazine derivative, production and use thereof |
-
1998
- 1998-07-07 BR BR9811678-9A patent/BR9811678A/pt not_active IP Right Cessation
- 1998-07-07 EP EP98941299A patent/EP1000040B1/de not_active Expired - Lifetime
- 1998-07-07 TR TR2000/00153T patent/TR200000153T2/xx unknown
- 1998-07-07 HR HR20000003A patent/HRP20000003A2/xx not_active Application Discontinuation
- 1998-07-07 KR KR19997012079A patent/KR20010014049A/ko not_active Withdrawn
- 1998-07-07 HU HU0004687A patent/HUP0004687A3/hu unknown
- 1998-07-07 ID IDW20000034A patent/ID24390A/id unknown
- 1998-07-07 AT AT98941299T patent/ATE364597T1/de not_active IP Right Cessation
- 1998-07-07 IL IL13391698A patent/IL133916A0/xx unknown
- 1998-07-07 SK SK1839-99A patent/SK183999A3/sk unknown
- 1998-07-07 JP JP50812699A patent/JP2002511882A/ja not_active Withdrawn
- 1998-07-07 CN CN98806978A patent/CN1262679A/zh active Pending
- 1998-07-07 AU AU89738/98A patent/AU742145B2/en not_active Ceased
- 1998-07-07 WO PCT/EP1998/004191 patent/WO1999002505A1/en not_active Ceased
- 1998-07-07 CA CA002294145A patent/CA2294145A1/en not_active Abandoned
- 1998-07-07 PL PL98337947A patent/PL337947A1/xx unknown
- 1998-07-07 NZ NZ502180A patent/NZ502180A/xx unknown
- 1998-07-07 EE EEP200000016A patent/EE200000016A/xx unknown
- 1998-07-07 DE DE69837922T patent/DE69837922D1/de not_active Expired - Lifetime
- 1998-07-08 TW TW087111014A patent/TW496865B/zh active
- 1998-07-08 AR ARP980103336A patent/AR013360A1/es not_active Application Discontinuation
- 1998-07-09 ZA ZA9806089A patent/ZA986089B/xx unknown
-
2000
- 2000-01-06 NO NO20000063A patent/NO20000063L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU742145B2 (en) | 2001-12-20 |
| NZ502180A (en) | 2000-11-24 |
| WO1999002505A1 (en) | 1999-01-21 |
| AU8973898A (en) | 1999-02-08 |
| BR9811678A (pt) | 2000-09-19 |
| IL133916A0 (en) | 2001-04-30 |
| DE69837922D1 (de) | 2007-07-26 |
| CA2294145A1 (en) | 1999-01-21 |
| EE200000016A (et) | 2000-10-16 |
| JP2002511882A (ja) | 2002-04-16 |
| TW496865B (en) | 2002-08-01 |
| HUP0004687A3 (en) | 2002-03-28 |
| ID24390A (id) | 2000-07-13 |
| TR200000153T2 (tr) | 2000-07-21 |
| EP1000040B1 (de) | 2007-06-13 |
| HUP0004687A2 (hu) | 2002-02-28 |
| ATE364597T1 (de) | 2007-07-15 |
| KR20010014049A (ko) | 2001-02-26 |
| CN1262679A (zh) | 2000-08-09 |
| ZA986089B (en) | 2000-01-10 |
| AR013360A1 (es) | 2000-12-27 |
| SK183999A3 (en) | 2000-08-14 |
| PL337947A1 (en) | 2000-09-11 |
| NO20000063D0 (no) | 2000-01-06 |
| HRP20000003A2 (en) | 2000-12-31 |
| EP1000040A1 (de) | 2000-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20000063L (no) | Nye IL-5 inhiberende 6-azauracilderivater | |
| HUP0301431A2 (hu) | 3-Indolil-4-fenil-1H-pirrol-2,5-dion-származékok, mint glikogén szintáz kináz-3béta inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| ES2193362T3 (es) | Derivados de 2-pirimidinamina y su procedimiento de preparacion de los mismos. | |
| PE20090151A1 (es) | Derivados de pirimidinona y metodos para su uso | |
| IE901799L (en) | Anti inflammatory aminophenol derivatives | |
| NO20004778L (no) | Amidderivater og nociceptin antagonister | |
| WO2006078621A3 (en) | 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders | |
| TW200621225A (en) | N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors | |
| NO20080456L (no) | Nye 2,4-dianilinopyrimidinderivater, fremstilling derav og deres anvendelse som medikamenter, farmasoytiske sammensetninger og, spesielt, som IKK inhibitorer | |
| MY146669A (en) | Pyrazole derivatives for treating hiv | |
| MY129796A (en) | Novel anti-inflammatory androstane derivatives | |
| TR200200778T2 (tr) | Pirazol türevleri. | |
| AR036906A1 (es) | Compuestos de imidazopiridin como moduladores del receptor 5-ht4 | |
| NO20063323L (no) | Pyrido- og pyrimidopyrimidinderivater | |
| PH12012500487A1 (en) | Herbicidal pyrimidone derivatives | |
| HUP0303326A2 (hu) | Benzofenonszármazékok, mint reverz transzkriptáz inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| TR200103683T2 (tr) | Indol türevleri ve bu türevlerin diğer uygulamaların yanısıra osteoporoz tedavisinde kullanımı | |
| MXPA04002495A (es) | Compuestos de imidazopiridin como moduladores del receptor 5-ht4. | |
| HUP0302157A2 (hu) | 4-(2-Fenil-tiazol-5-il)-1,4-diazabiciklo[3.2.2]nonán-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények | |
| MY116952A (en) | 4 substituted 2-carboxy-tetrahydroquinoline derivatives, pharmaceutical compositions comprising them and process for their preparation | |
| MX2009001255A (es) | Agente mejorador de la actividad de la proteina qunasa c que contiene un derivado de alquileter o una sal del mismo. | |
| ATE44748T1 (de) | 4-substituierte 6-alkylidene-androsten-3,17-dion- derivate und verfahren zu ihrer herstellung. | |
| HRP20080119T5 (en) | Benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same | |
| UY29015A1 (es) | Derivados de pirido-pirimidina, su preparacinn, su aplicacinn en terapeutica | |
| ES2196332T3 (es) | Derivados de hexahidro-pirido(4,3-b)indol como farmacos antipsicoticos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |